SCHEMBL3731480

SCHEMBL3731480

COc1ncc(-c2ccccc2N2CCN(C(C=O)n3cc4ccccc4n3)CC2)cn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC8 Q9BY41 1/20 0.39
DHFR P00374 2/20 0.36
HTR1A P08908 7/20 0.33
HTR7 P34969 6/20 0.33
MAPK1 P28482 2/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C9 P11712 1/20 0.33
HSD17B10 Q99714 1/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
KCNH2 Q12809 1/20 0.33
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32
KMT2A Q03164 1/20 0.32
DRD2 P14416 1/20 0.31
HTR2A P28223 1/20 0.31
HTR2C P28335 1/20 0.31
DRD3 P35462 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL111928 0.80 FAAH (0.34) DHFRHTR1AHTR7ALDH1A1MEN1
SCHEMBL114268 0.79 CXCR3 (0.40) DHFRHTR1AHTR7HSD17B10KCNH2
SCHEMBL116262 0.78 CXCR3 (0.35) DHFRHTR1AHTR7MAPK1ALDH1A1
SCHEMBL113266 0.78 DHFR (0.35) DHFRHTR1AHTR7MAPK1ALDH1A1
SCHEMBL113465 0.77 HTR7 (0.34) DHFRHTR1AHTR7MAPK1ALDH1A1
SCHEMBL116207 0.76 DHFR (0.33) DHFRHTR1AHTR7MAPK1ALDH1A1
SCHEMBL115607 0.76 HTR1A (0.37) DHFRHTR1AHTR7MAPK1ALDH1A1
SCHEMBL113317 0.75 DHFR (0.35) DHFRHTR1AHTR7MAPK1ALDH1A1
SCHEMBL113245 0.75 AGER (0.36) DHFRHTR1AHTR7CYP1A2CYP3A4
SCHEMBL115724 0.74 DHFR (0.33) DHFRHTR1AHTR7KCNH2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8450317-B2 CXCR3 receptor antagonists BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2013-05-28 US disclosed
US-20100280028-A1 CXCR3 RECEPTOR ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-11-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100280028-A1 CXCR3 RECEPTOR ANTAGONISTS CXCR3, CXCR1, CXCR2 HDAC8 3974/4885DHFR 1188/4885HTR1A 577/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.